USPTO serial 98330224
CENCORA
Reviewed by CopyMark Law Group
Status 819
- Filing date
- Status date
- Registration date
- —
- Examiner
- KEATING, MICHAEL P
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CENCORA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Conshohocken, PA, US
Conshohocken, PA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anita B. Polott
Anita B. Polott Morgan, Lewis & Bockius LLP1111 Pennsylvania Avenue, NWAttention: TMSUWashington, DC 20004-2541Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 045 | Public document filing assistance in the field of medicine authorization, namely, public document filing services pertaining to documents for authorizing medicines and filing documents, reports and files required by regulatory authorities; regulatory compliance consultancy in the field of pharmaceuticals; Regulatory compliance consulting in the field of clinical trials, pharmacovigilance, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, biosimilars, medicines and medical products; Regulatory research in the field of health care; Regulatory compliance auditing; regulatory compliance consulting services in the field of pharmaceuticals, medical devices, and biopharmaceuticals; regulatory support and advice, namely, regulatory compliance consulting in the field of drug approval; regulatory compliance auditing in the nature of submission of documents, reports and records required for drug approval by regulatory authorities; consultancy services in the fields of regulatory compliance and oversight in the field of pharmaceuticals, medical devices, and biopharmaceuticals; advisory services relating to regulatory compliance auditing regulatory maintenance of marketing authorizations, namely, tracking and monitoring regulatory requirements in the field of pharmaceuticals for regulatory compliance purposes following pharmaceutical approval | ACTIVE | Aug 30, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 8, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 7, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 22, 2026 | IUAF | USE AMENDMENT FILED | — |
| Sep 22, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 14, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 13, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 13, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 13, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 14, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 13, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 13, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 13, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 11, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 10, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 10, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 10, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 14, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 11, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 11, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 25, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 26, 2023 | NWAP | NEW APPLICATION ENTERED | — |